Treatment of Refractory Schizophrenia With Riluzole

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2002
Cargando información sobre las referencias
The proposed study would evaluate the benefits of riluzole add-on treatment to patients with schizophrenia who are already receiving medications, but still experience symptoms. Neuroprotective medication riluzole is currently approved for treatment of amyotrophic lateral sclerosis (Lou Gehrig\'s disease), a severe neurological illness. Due to its unique mechanism of action, riluzole, if effective in helping the symptoms of schizophrenia, would open novel directions in treatment of schizophrenia.
Epistemonikos ID: 6141d17a961c547446bd3f6e98e10ce87c2a2a1d
First added on: May 04, 2024